Variations in MAP kinase gladiators and risk of differentiated thyroid carcinoma

Thyroid carcinoma (TC) accounts for ~2.1% of newly diagnosed cancer cases. Mutations in KRAS, HRAS, NRAS and BRAF are primary participants in the development and progression of various types of malignancy, including differentiated TC (DTC). Therefore, the present prospective cohort study aimed to sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Faiza A., Bhat, Ghulam Hassan, Khan, Mosin S., Tabassum, Sobia, Bhat, Mohammad Hayat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739702/
https://www.ncbi.nlm.nih.gov/pubmed/35003743
http://dx.doi.org/10.3892/mco.2021.2478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739702/
https://www.ncbi.nlm.nih.gov/pubmed/35003743
http://dx.doi.org/10.3892/mco.2021.2478

Ejemplares similares